Is JNJ Worth Buying in 2026?

Johnson & Johnson

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Johnson & Johnson (JNJ) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 60 — healthy momentum range; strong 1-year return of +53.8%. Concerns: 50-day MA is falling (-0.66% over 10 days). Currently 4.3% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

JNJ is in a confirmed uptrend, trading above both its 50-day ($230.97) and 200-day ($214.60) moving averages. An RSI of 59.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +53.8% compares to +22.9% for SPY (beat the market by 30.9%).

$10,000 invested 1 year ago → $15,375 today
vs. S&P 500 (SPY) — same period beat market by 30.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($214.60)
Above 50-day MA ($230.97)
RSI(14) neutral zone (30–70) — currently 59.8
Positive return (+53.8%)
Within 10% of period high (−4.3%)
Period Range $240.87
$149.04 $251.71
RSI (14) 59.8
0 · OversoldOverbought · 100

Key Metrics

Price$240.87
Period Return+53.8%
Period High$251.71
Period Low$149.04
Drawdown−4.3%
MA-50$230.97
MA-200$214.60
RSI (14)59.8
Avg Volume (30d)7.6M
vs. SPYbeat by 30.9%
Return Rank#325 of 1246

Trade JNJ

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers